Hochhegger Bruno, Alves Giordano Rafael Tronco, Irion Klaus Loureiro, Fritscher Carlos Cezar, Fritscher Leandro Genehr, Concatto Natália Henz, Marchiori Edson
Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Radiology Department, Royal Liverpool and Broadgreen University Hospital, Liverpool, United Kingdom.
J Bras Pneumol. 2015 May-Jun;41(3):264-74. doi: 10.1590/S1806-37132015000004479.
The use of PET/CT imaging in the work-up and management of patients with lung cancer has greatly increased in recent decades. The ability to combine functional and anatomical information has equipped PET/CT to look into various aspects of lung cancer, allowing more precise disease staging and providing useful data during the characterization of indeterminate pulmonary nodules. In addition, the accuracy of PET/CT has been shown to be greater than is that of conventional modalities in some scenarios, making PET/CT a valuable noninvasive method for the investigation of lung cancer. However, the interpretation of PET/CT findings presents numerous pitfalls and potential confounders. Therefore, it is imperative for pulmonologists and radiologists to familiarize themselves with the most relevant indications for and limitations of PET/CT, seeking to protect their patients from unnecessary radiation exposure and inappropriate treatment. This review article aimed to summarize the basic principles, indications, cancer staging considerations, and future applications related to the use of PET/CT in lung cancer.
近几十年来,PET/CT成像在肺癌患者的检查和管理中的应用大幅增加。结合功能和解剖信息的能力使PET/CT能够深入研究肺癌的各个方面,实现更精确的疾病分期,并在对不确定的肺结节进行特征描述时提供有用数据。此外,在某些情况下,PET/CT的准确性已被证明高于传统检查方式,这使PET/CT成为一种有价值的肺癌无创检查方法。然而,对PET/CT检查结果的解读存在许多陷阱和潜在干扰因素。因此,肺科医生和放射科医生必须熟悉PET/CT最相关的适应证和局限性,避免让患者受到不必要的辐射暴露和不适当的治疗。这篇综述文章旨在总结与PET/CT在肺癌中的应用相关的基本原则、适应证、癌症分期考量及未来应用。